Albumin nanoparticles have attracted much attentionin recent years due to their remarkable capacity to load a varietyof drugs nonspecifically and their safety when administered in vivo., Albumin-bound nanoparticles can promote tumor drug accumulationusing the well-known passive targeting mechanism, enhanced permeability,and retention (EPR) effect. This evidence concerns the gene ALB and neoplasm.